We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hill-Rom Introduces VisiVest, First Connected Airways System
Read MoreHide Full Article
Medical technology company, Hill-Rom Holdings, Inc. recently launched VisiVest System, the world’s first wirelessly connected airway clearance system. Hill-Rom claims that this solution provides therapy adherence data that will enable caregivers to take more custom-made and responsive treatment decisions, thereby resulting in reduced risk of respiratory infections, hospitalizations and medical costs.
The VisiVest System solution has been created by combining the company’s high-frequency chest-wall oscillation (HFCWO) technology with wireless connectivity from Qualcomm Life, a subsidiary of Qualcomm Incorporated. According to the company, patients’ usage data from the VisiVest System will be remotely and securely transmitted to the VisiView Health Portal via Qualcomm Life's 2net Hub.
Taking into consideration the importance of accurate, timely information for treatment decisions in the healthcare space, we understand the necessity of this kind of system. By combining Hill-Rom and Qualcomm Life's expertise, we believe the system will show high market adoption rate down the line.
We note that due to the growing population of the elderly and obese, there are rising incidences of complex diseases and conditions such as diabetes, congestive heart failure and respiratory disease. Patients are being moved through the hospital faster and generally desire to rapidly shift to lower acuity settings. This trend indicates an increase in the demand for more sophisticated means to deliver care for these patients, such as improved medical technologies, communication tools and information technologies. This, in turn, expands Hill-Rom’s scope of growth.
We believe the company’s constant efforts to meet changing demand with new and differentiated products will increase its ability to drive revenues and improve margins further, going forward.
Currently, Hill-Rom carries a Zacks Rank #3 (Hold).
Key Picks in the Sector
Some better-ranked medical products stocks are ICU Medical, Inc. (ICUI - Free Report) , LeMaitre Vascular, Inc. (LMAT - Free Report) and NuVasive, Inc. . All three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Hill-Rom Introduces VisiVest, First Connected Airways System
Medical technology company, Hill-Rom Holdings, Inc. recently launched VisiVest System, the world’s first wirelessly connected airway clearance system. Hill-Rom claims that this solution provides therapy adherence data that will enable caregivers to take more custom-made and responsive treatment decisions, thereby resulting in reduced risk of respiratory infections, hospitalizations and medical costs.
The VisiVest System solution has been created by combining the company’s high-frequency chest-wall oscillation (HFCWO) technology with wireless connectivity from Qualcomm Life, a subsidiary of Qualcomm Incorporated. According to the company, patients’ usage data from the VisiVest System will be remotely and securely transmitted to the VisiView Health Portal via Qualcomm Life's 2net Hub.
Taking into consideration the importance of accurate, timely information for treatment decisions in the healthcare space, we understand the necessity of this kind of system. By combining Hill-Rom and Qualcomm Life's expertise, we believe the system will show high market adoption rate down the line.
We note that due to the growing population of the elderly and obese, there are rising incidences of complex diseases and conditions such as diabetes, congestive heart failure and respiratory disease. Patients are being moved through the hospital faster and generally desire to rapidly shift to lower acuity settings. This trend indicates an increase in the demand for more sophisticated means to deliver care for these patients, such as improved medical technologies, communication tools and information technologies. This, in turn, expands Hill-Rom’s scope of growth.
We believe the company’s constant efforts to meet changing demand with new and differentiated products will increase its ability to drive revenues and improve margins further, going forward.
Currently, Hill-Rom carries a Zacks Rank #3 (Hold).
Key Picks in the Sector
Some better-ranked medical products stocks are ICU Medical, Inc. (ICUI - Free Report) , LeMaitre Vascular, Inc. (LMAT - Free Report) and NuVasive, Inc. . All three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>